U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • Update information Minor updates since publication July 2019: Because of a risk of abuse and dependence, gabapentin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A footnote has been amended to reflect this change.

Update information Minor updates since publication July 2019: Because of a risk of abuse and dependence, gabapentin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A footnote has been amended to reflect this change.

Cover of End of Life Care for Infants, Children and Young People with Life-Limiting Conditions: Planning and Management

End of Life Care for Infants, Children and Young People with Life-Limiting Conditions: Planning and Management

NICE Guideline, No. 61

.

This guideline covers the physical, emotional, social and spiritual elements of end of life care, and focuses on improving the child or young person’s quality of life and supporting their family and carers. There are, for instance, recommendations on managing distressing symptoms and providing care and bereavement support after death. Recommendations have also been made about how services should be delivered. The guideline is aimed at all providers of paediatric end of life care, whatever their level of practise, and also for children and young people with life-limiting conditions and their parents or carers.

The guideline covers children and young people with a life-limiting condition. It does not make recommendations for children or young people who die suddenly and unexpectedly (for example due to accidental death).

Contents

Developed by the National Guideline Alliance, hosted by the Royal College of Obstetricians and Gynaecologists

Disclaimer: Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer.

Copyright, National Institute for Health and Care Excellence, 2016.
Bookshelf ID: NBK402430PMID: 28045476

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (6.4M)

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...